Incidence of spina bifida in Santa Catarina (2013-2022): ecological study
DOI:
https://doi.org/10.34024/rnc.2025.v33.20482Keywords:
Spina Bifida, Spinal Dysraphism, Myelomeningocele, BrazilAbstract
Introduction. Neural tube defects (NTDs) are congenital anomalies affecting the central nervous system in early embryonic weeks, with spina bifida being a common manifestation, presenting neurological, orthopedic, and urological symptoms. Genetic and environmental factors contribute to these anomalies. Improved prenatal diagnosis and a multidisciplinary approach from gestation are crucial to minimizing complications. Method. This ecological study analyzed spina bifida cases in all children born in Santa Catarina between 2013 and 2022, using DataSUS data. Information about the population and statistical tools studied was provided. Results. In Santa Catarina, there were 223 spina bifida cases (23.13 per 100,000 inhabitants). The most affected cities were Joinville, Florianópolis, and São José. Incidence was higher among males, with the highest prevalence in pregnant women aged 25 to 29. Most newborns had high Apgar scores and weights between 3000–3999 grams. Blumenau recorded 41 deaths, the highest number. No significant gender differences were found. The decline in spina bifida cases may be linked to folic acid fortification. The predominance of males and the white demographic, along with incidence among younger pregnant women, highlight sociodemographic and healthcare access issues. High Apgar scores underscore the importance of early evaluation, while mortality rates emphasize the need for continuous monitoring to reduce morbidity and mortality. Conclusions. The study reiterates the importance of health policies and clinical practices to reduce spina bifida incidence and improve the quality of life of affected patients.
Metrics
References
1.Schindelmann KH, Paschereit F, Steege A, Stoltenburg-Didinger G, Kaindl AM. Systematic classification of spina bifida. J Neuropathol Exp Neurol 2021;80:294-305. https://doi.org/10.1093/jnen/nlab007
2.Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM. Spina bifida. Nat Rev Dis Primers 2015;1:15007. https://doi.org/10.1038/nrdp.2015.7
3.Bronzeri FG, Faria TS, Silva FS, Coimbra PC, Frangella VS. Mielomeningocele e nutrição: proposta de protocolo de atendimento. Mundo Saúde 2011;35:215-24. https://doi.org/10.15343/0104-7809.20112215224
4.Protzenko T, Bellas A, Pousa MS, Protzenko M, Fontes JM, Silveira AML, et al. Reviewing the prognostic factors in myelomeningocele. Neurosurg Focus 2019;47:E2. https://doi.org/10.3171/2019.7.FOCUS19462
5.Hassan AE, Du YL, Lee SY, Wang A, Farmer DL. Spina bifida: a review of the genetics, pathophysiology and emerging cellular therapies. J Dev Biol 2022;10:22. https://doi.org/10.3390/jdb10020022
6.Vieira RS, Diogo CMS, Vieira CLJ, Silva JS, Nascimento JC, Tavares MM. Cuidados de Enfermagem prestados à criança portadora de mielomeningocele e suas complicações. Rev Pró Univer SUS 2021;12:94-101. https://doi.org/10.21727/rpu.v12i2.2712
7.Pereira-Mata R, Franco A, Gago C, Pacheco A. Diagnóstico pré-natal de defeitos do tubo neural. Acta Obstet Ginecol Port 2018;12:144-35. https://scielo.pt/pdf/aogp/v12n2/v12n2a07.pdf
8.Christianson A, Howson CP, Modell B. March of Dimes global report on birth defects: the hidden toll of dying and disabled children. White Plains: March of Dimes Birth Defects Foundation; 2006.
9.Campos JR, Souto JV, Machado LC. Estudo epidemiológico de nascidos vivos com Espinha Bífida no Brasil. Braz J Health Rev 2021;4:9693-700. https://doi.org/10.34119/bjhrv4n3-008
10.Mariani Neto C. Prevenção dos defeitos abertos do tubo neural – DTN. 2ª ed. São Paulo: FEBRASGO; 2020.
11.Bizzi JWJ, Machado A. Mielomeningocele: conceitos básicos e avanços recentes. J Bras Neurocir 2012;23:138-51. https://doi.org/10.22290/jbnc.v23i2.1161
12.Almeida MC, Veloso ML, Camilo JC, Spósito TS, Pacheco LG, Pacheco GG, et al. Condutas terapêuticas para mielomeningocele. Res Soc Dev 2022;11:e34711628983. https://doi.org/10.33448/rsd-v11i6.28983
13.Agência Nacional de Vigilância Sanitária (ANVISA). Relatório do Monitoramento da Fortificação de Farinhas de Trigo e Milho com Ferro e Ácido Fólico (2020 e 2021). Brasília: ANVISA; 2022. https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/monitoramento/programas-nacionais-de-monitoramento-de-alimentos/RelatriodeFortificaodeFarinhasdeTrigoeMilhocomFerroecidoFlicop.pdf
14.Fujimori E, Baldino CF, Sato APS, Borges ALV, Gomes MN. Prevalência e distribuição espacial de defeitos do tubo neural no Estado de São Paulo, Brasil, antes e após a fortificação de farinhas com ácido fólico. Cad Saúde Pública 2013;29:145-54. https://doi.org/10.1590/S0102-311X2013000500017
15.Programa de Qualificação de Operadoras ano-base 2022. Brasília: Diretoria de Desenvolvimento Setorial; 2022. https://www.gov.br/ans/pt-br/assuntos/informacoes-e-avaliacoes-de-operadoras/1.2.TaxadeConsultasdePrNatal.pdf
16.Fernandes FCGM, Santos EGO, Barbosa IR. Age of first pregnancy in Brazil: data from the national health survey. J Hum Growth Dev 2019;29:304-12. https://doi.org/10.7322/jhgd.v29.9523
17.Estadão. Brasileiras estão tendo menos filhos, com exceção das mulheres de 40 a 49 anos; entenda os motivos (internet). São Paulo: Estadão; 2023. Disponível em: https://www.estadao.com.br/brasil/brasileiras-estao-tendo-menos-filhos-com-excecao-das-mulheres-de-40-a-49-anos-entenda-os-motivos/
18.Schardosim JM, Rodrigues NLDA, Rattner D. Parâmetros utilizados na avaliação de bem-estar do bebê no nascimento. Avances Enferm 2018;36:187-208. https://doi.org/10.15446/av.enferm.v36n2.67809
19.Figueiredo LSS, Andrade TOLA, Abreu Neto AV, Melo BG, Cruz IS. Perfil epidemiológico de mortalidade por espinha bífida. Rev Soc Bras Clin Med 2019;17:171-3. https://www.sbcm.org.br/ojs3/index.php/rsbcm/article/view/712
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Jucélia Jeremias Fortunato, Kelser De Souza Kock, Chaiana Esmeraldino Mendes Marcon, Guilherme Xavier Wensing, Pedro Miguel Ghizoni Pereira, Thamara Vieira Bitencourt

This work is licensed under a Creative Commons Attribution 4.0 International License.
